Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

2.

Subphenotype meta-analysis of testicular cancer genome-wide association study data suggests a role for RBFOX family genes in cryptorchidism susceptibility.

Wang Y, Gray DR, Robbins AK, Crowgey EL, Chanock SJ, Greene MH, McGlynn KA, Nathanson K, Turnbull C, Wang Z, Devoto M, Barthold JS; Testicular Cancer Consortium.

Hum Reprod. 2018 May 1;33(5):967-977. doi: 10.1093/humrep/dey066.

PMID:
29618007
3.

Diiron Dithiolate Hydrides Complemented with Proton-Responsive Phosphine-Amine Ligands.

Carlson MR, Gilbert-Wilson R, Gray DR, Mitra J, Rauchfuss TB, Richers CP.

Eur J Inorg Chem. 2017 Jul 7;2017(25):3169-3173. doi: 10.1002/ejic.201700474. Epub 2017 Jul 5.

4.

The Value of Independent Specialty Designation for Interventional Cardiology. DOI: 10.1002/ccd.26656.

Blankenship JC, Powell WA, Gray DR, Duffy PL.

Catheter Cardiovasc Interv. 2017 Jul;90(1):173. doi: 10.1002/ccd.27194. No abstract available.

PMID:
28707439
5.

The value of independent specialty designation for interventional cardiology.

Blankenship JC, Powell WA, Gray DR, Duffy PL.

Catheter Cardiovasc Interv. 2017 Jan;89(1):97-101. doi: 10.1002/ccd.26656. Epub 2016 Oct 19. Erratum in: Catheter Cardiovasc Interv. 2017 Jul;90(1):173.

PMID:
27759184
6.

Model-specification uncertainty in future forest pest outbreak.

Boulanger Y, Gray DR, Cooke BJ, De Grandpré L.

Glob Chang Biol. 2016 Apr;22(4):1595-607. doi: 10.1111/gcb.13142. Epub 2016 Feb 9.

PMID:
26511654
7.

Optical side scattering radiometry for high resolution, wide dynamic range longitudinal assessment of optical fibers.

Sandoghchi SR, Petrovich M, Gray DR, Chen Y, Wheeler NV, Bradley TD, Wong NH, Jasion GT, Hayes J, Fokoua EN, Alonso MB, Mousavi SM, Richardson DJ, Poletti F.

Opt Express. 2015 Oct 19;23(21):27960-74. doi: 10.1364/OE.23.027960.

PMID:
26480455
9.

Accurate calibration of S(2) and interferometry based multimode fiber characterization techniques.

Gray DR, Sandoghchi SR, Wheeler NV, Baddela NK, Jasion GT, Petrovich MN, Poletti F, Richardson DJ.

Opt Express. 2015 Apr 20;23(8):10540-52. doi: 10.1364/OE.23.010540.

PMID:
25969094
10.

X-ray tomography for structural analysis of microstructured and multimaterial optical fibers and preforms.

Sandoghchi SR, Jasion GT, Wheeler NV, Jain S, Lian Z, Wooler JP, Boardman RP, Baddela N, Chen Y, Hayes J, Fokoua EN, Bradley T, Gray DR, Mousavi SM, Petrovich M, Poletti F, Richardson DJ.

Opt Express. 2014 Oct 20;22(21):26181-92. doi: 10.1364/OE.22.026181.

PMID:
25401650
11.

Demonstration of amplified data transmission at 2 µm in a low-loss wide bandwidth hollow core photonic bandgap fiber.

Petrovich MN, Poletti F, Wooler JP, Heidt AM, Baddela NK, Li Z, Gray DR, Slavík R, Parmigiani F, Wheeler NV, Hayes JR, Numkam E, Grűner-Nielsen L, Pálsdóttir B, Phelan R, Kelly B, O'Carroll J, Becker M, MacSuibhne N, Zhao J, Gunning FC, Ellis AD, Petropoulos P, Alam SU, Richardson DJ.

Opt Express. 2013 Nov 18;21(23):28559-69. doi: 10.1364/OE.21.028559.

PMID:
24514368
12.

Fire regime zonation under current and future climate over eastern Canada.

Boulanger Y, Gauthier S, Gray DR, Le Goff H, Lefort P, Morissette J.

Ecol Appl. 2013 Jun;23(4):904-23.

PMID:
23865239
13.

Unwanted spatial bias in predicting establishment of an invasive insect based on simulated demographics.

Gray DR.

Int J Biometeorol. 2014 Jul;58(5):949-61. doi: 10.1007/s00484-013-0678-3. Epub 2013 Jun 9.

PMID:
23748421
14.

Perfluorodecalin-enriched fibrin matrix for human islet culture.

Maillard E, Juszczak MT, Clark A, Hughes SJ, Gray DR, Johnson PR.

Biomaterials. 2011 Dec;32(35):9282-9. doi: 10.1016/j.biomaterials.2011.08.044. Epub 2011 Sep 6.

PMID:
21899883
15.

Prepupal diapause and instar IV developmental rates of the spruce beetle, Dendroctonus rufipennis (Coleoptera: Curculionidae, Scolytinae).

Hansen EM, Bentz BJ, Powell JA, Gray DR, Vandygriff JC.

J Insect Physiol. 2011 Oct;57(10):1347-57. doi: 10.1016/j.jinsphys.2011.06.011. Epub 2011 Jun 29.

PMID:
21740908
17.
18.

Androgen deprivation induces rapid involution and recovery of human prostate vasculature.

Godoy A, Montecinos VP, Gray DR, Sotomayor P, Yau JM, Vethanayagam RR, Singh S, Mohler JL, Smith GJ.

Am J Physiol Endocrinol Metab. 2011 Feb;300(2):E263-75. doi: 10.1152/ajpendo.00210.2010. Epub 2010 Aug 10.

19.

Application of monoclonal antibodies to measure metabolism of an anti-trypanosomal compound in vitro and in vivo.

Goldsmith RB, Gray DR, Yan Z, Generaux CN, Tidwell RR, Reisner HM.

J Clin Lab Anal. 2010;24(3):187-94. doi: 10.1002/jcla.20380. Erratum in: J Clin Lab Anal. 2011;25(4):309.

PMID:
20486201
20.
21.

Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model.

Huss WJ, Gray DR, Tavakoli K, Marmillion ME, Durham LE, Johnson MA, Greenberg NM, Smith GJ.

Neoplasia. 2007 Nov;9(11):938-50.

22.

Risk assessment in the face of a changing environment: gypsy moth and climate change in Utah.

Logan JA, Régnière J, Gray DR, Munson AS.

Ecol Appl. 2007 Jan;17(1):101-17.

PMID:
17479838
23.

Cost-justification of a clinical pharmacist-managed anticoagulation clinic.

Gray DR, Garabedian-Ruffalo SM, Chretien SD.

Ann Pharmacother. 2007 Mar;41(3):496-501. Epub 2007 Mar 6.

PMID:
17341522
24.

Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells.

Huss WJ, Gray DR, Greenberg NM, Mohler JL, Smith GJ.

Cancer Res. 2005 Aug 1;65(15):6640-50.

25.

Endoscopic lesser saphenous vein harvesting for coronary artery bypass grafting: first reported case.

Nickum CW, Dullum MK, Boyd WD, Gray DR.

Innovations (Phila). 2005 Winter;1(2):96-7.

PMID:
22436552
26.

Evidence of pluripotent human prostate stem cells in a human prostate primary xenograft model.

Huss WJ, Gray DR, Werdin ES, Funkhouser WK Jr, Smith GJ.

Prostate. 2004 Jul 1;60(2):77-90.

PMID:
15162374
27.

New perspectives on the pharmacotherapy of ischemic stroke.

Bradberry JC, Fagan SC, Gray DR, Moon YS.

J Am Pharm Assoc (2003). 2004 Mar-Apr;44(2 Suppl 1):S46-56; quiz S56-7. Review.

PMID:
15095935
28.

Short-term human prostate primary xenografts: an in vivo model of human prostate cancer vasculature and angiogenesis.

Gray DR, Huss WJ, Yau JM, Durham LE, Werdin ES, Funkhouser WK Jr, Smith GJ.

Cancer Res. 2004 Mar 1;64(5):1712-21.

29.

Quantitative comparison of long-wavelength Alexa Fluor dyes to Cy dyes: fluorescence of the dyes and their bioconjugates.

Berlier JE, Rothe A, Buller G, Bradford J, Gray DR, Filanoski BJ, Telford WG, Yue S, Liu J, Cheung CY, Chang W, Hirsch JD, Beechem JM, Haugland RP, Haugland RP.

J Histochem Cytochem. 2003 Dec;51(12):1699-712.

PMID:
14623938
30.

Diapause in the gypsy moth: a model of inhibition and development.

Gray DR, Ravlin FW, Braine JA.

J Insect Physiol. 2001 Feb 1;47(2):173-184.

PMID:
11064024
31.

Immunoassays for pentamidine and related compounds: development of a facile inhibitory ELISA suitable for clinical use.

Reisner HM, Gray DR, Jones SK, Rose BG, Tidwell RR.

J Clin Lab Anal. 2000;14(2):73-82.

PMID:
10683618
32.

Impact of therapeutic interchange from pravastatin to lovastatin in a Veterans Affairs Medical Center.

Patel RJ, Gray DR, Pierce R, Jafari M.

Am J Manag Care. 1999 Apr;5(4):465-74.

33.
34.

Effect of pharmaceutical care on optimum colestipol treatment in elderly hypercholesterolemic veterans.

Konzem SL, Gray DR, Kashyap ML.

Pharmacotherapy. 1997 May-Jun;17(3):576-83.

PMID:
9165562
35.

Fish oil as an adjuvant in the treatment of hypertension.

Gray DR, Gozzip CG, Eastham JH, Kashyap ML.

Pharmacotherapy. 1996 Mar-Apr;16(2):295-300.

PMID:
8820475
36.

CO(2) in large-scale and high-density CHO cell perfusion culture.

Gray DR, Chen S, Howarth W, Inlow D, Maiorella BL.

Cytotechnology. 1996 Jan;22(1-3):65-78. doi: 10.1007/BF00353925.

PMID:
22358916
37.

Efficacy and safety of controlled-release niacin in dyslipoproteinemic veterans.

Gray DR, Morgan T, Chretien SD, Kashyap ML.

Ann Intern Med. 1994 Aug 15;121(4):252-8.

PMID:
7741833
38.

Lower limb ischaemia in the octogenarian: is limb salvage surgery worthwhile?

O'Brien TS, Lamont PM, Crow A, Gray DR, Collin J, Morris PJ.

Ann R Coll Surg Engl. 1993 Nov;75(6):445-7.

39.

Chlorpropamide-induced hyponatremia in the veteran population.

Hirokawa CA, Gray DR.

Ann Pharmacother. 1992 Oct;26(10):1243-4.

PMID:
1421649
40.

Documentation and assessment of pharmacist-initiated drug therapy interventions.

Gray DR.

Top Hosp Pharm Manage. 1992 Jan;11(4):69-79.

PMID:
10128689
41.

Responding to a physician's request to mislabel a patient's prescription.

Clyne KE, Gray DR, Veatch RM.

Am J Hosp Pharm. 1991 Feb;48(2):296; discussion 296-300. No abstract available.

PMID:
2003505
42.

Promotion of extended-release niacin tablets at a Veterans Affairs medical center.

Wu FF, Gray DR.

Am J Hosp Pharm. 1990 Sep;47(9):2031-4.

PMID:
2220857
43.

Gentamicin bioavailability and single-dose pharmacokinetics in spinal cord injury.

Segal JL, Brunnemann SR, Gray DR.

Drug Intell Clin Pharm. 1988 Jun;22(6):461-5.

PMID:
3396458
44.

Effect of two cimetidine regimens on prothrombin time and warfarin pharmacokinetics during long-term warfarin therapy.

Sax MJ, Randolph WC, Peace KE, Chretien S, Frank WO, Braverman AJ, Gray DR, McCree LC, Wyle F, Jackson BJ, et al.

Clin Pharm. 1987 Jun;6(6):492-5. No abstract available. Erratum in: Clin Pharm 1988 Apr;7(4):269.

PMID:
3690995
45.

Workload measurement of a clinical pharmacy residency program.

Gray DR, Ho MI, Cavale KL, Maki JK, Flader JA, Chretien SD.

Am J Hosp Pharm. 1987 Mar;44(3):557-61.

PMID:
3565413
46.

Treatment of gynecomastia with tamoxifen: a double-blind crossover study.

Parker LN, Gray DR, Lai MK, Levin ER.

Metabolism. 1986 Aug;35(8):705-8.

PMID:
3526085
47.

Cost-justification of a clinical pharmacist-managed anticoagulation clinic.

Gray DR, Garabedian-Ruffalo SM, Chretien SD.

Drug Intell Clin Pharm. 1985 Jul-Aug;19(7-8):575-80.

PMID:
3928310
48.

Gentamicin disposition kinetics in humans with spinal cord injury.

Segal JL, Gray DR, Gordon SK, Eltorai IM, Khonsari F, Patel J.

Paraplegia. 1985 Feb;23(1):47-55.

49.

Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic.

Garabedian-Ruffalo SM, Gray DR, Sax MJ, Ruffalo RL.

Am J Hosp Pharm. 1985 Feb;42(2):304-8.

PMID:
3976675
50.

Warfarin interaction with erythromycin.

Sato RI, Gray DR, Brown SE.

Arch Intern Med. 1984 Dec;144(12):2413-4.

PMID:
6508448

Supplemental Content

Support Center